Immunotherapy has shown encouraging results in various cancers, but the response rates
are relatively low due to the complex tumor immunosuppressive microenvironment (TIME). …

Most of the current nanoparticle‐based therapeutics worldwide failing in clinical trials face
three major challenges: (i) lack of an optimum drug delivery platform with precise composition, …

Current standard of care dressings are unsatisfactorily inefficacious for the treatment of chronic
wounds. Chronic inflammation is the primary cause of the long‐term incurable nature of …

Intraoperative bleeding is an essential factor leading to the earliest recurrence and tumor
metastasis frequently seen after resection of solid tumors. Local drug delivery implants show …

The development of a controllable reactive nitrogen species (RNS) generation system for
cancer treatment has remained elusive. Herein, a supramolecular prodrug nanoassemblies (…

Platinum drugs comprise of almost 50% of all currently used anticancer drugs. They are now
widely used in the clinical therapy of various solid tumors, including ovarian, head and neck…

Metal-based drugs have drawn significant attention over the past few decades due to their
advanced properties and benefits in biomedical therapeutic and diagnostic systems. Among …

Drug, targeting ligand, and imaging agent are the three essential components in a
nanoparticle-based drug delivery system. However, tremendous batch-to-batch variation of …

Combination of chemotherapy and gene therapy provides an effective strategy for cancer
treatment. However, the lack of suitable codelivery systems with efficient endo/lysosomal …

This article proposes a new class of box-like substrate integrated waveguide (SIW) filters with
wide stopband. First, a two-pole doublet bandpass filter with one finite-transmission zero (…